Metformin ameliorates learning and memory deficits in streptozotocin-induced diabetic rats

Document Type: Research Paper

Authors

1 Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

2 Neurophysiology Research Center, Shahed University, Tehran, Iran

Abstract

Background and Objective: Diabetes mellitus (DM) in long-term is associated with learning and memory decline. Metformin is an anti-diabetic drug with antioxidant and memory-improving effects. Thus, this research study was conducted to assess the effect of metformin on learning and memory in diabetic rats.
Materials and Methods: In the present study, male Wistar rats (n=32) were randomly assigned to 4 groups: control, control treated with metformin (200 mg/kg), diabetic, and diabetic treated with metformin (200 mg/kg). Diabetes was induced by streptozotocin (STZ) at a dose of 60 mg/kg. Metformin was administered i.p. at a dose of 200 mg/kg one week after STZ injection for 7 weeks. Blood sample was taken from retro-orbital plexus before STZ injection and 4 and 8 weeks after STZ injection to measure blood glucose level. Passive avoidance and Y maze tests were performed to evaluate learning and memory dysfunctions.
Results: After 8 weeks, diabetic rats showed a significant cognitive decline in passive avoidance and Y maze tests that was significantly improved after metformin treatment. In addition, metformin exerted a significant hypoglycemic effect in this model of DM.
Conclusion: This study clearly showed that treatment with metformin for 7 weeks could ameliorate cognitive decline in diabetic animals and part of its beneficial effect is due to its hypoglycemic effect.

Keywords


  1. da Costa M, Bernardi J, Costa L, Fiuza T, Brandao R, Ribeiro MF, et al. N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin. Chemico-Biological Interactions 2017;272:37-46.
  2. 2.     Zou W, Yuan J, Tang ZJ, Wei HJ, Zhu WW, Zhang P, et al. Hydrogen sulfide ameliorates cognitive dysfunction in streptozotocin-induced diabetic rats: involving suppression in hippocampal endoplasmic reticulum stress. Oncotarget 2017.
  3. Kennedy JM, Zochodne DW. Impaired peripheral nerve regeneration in diabetes mellitus. Journal of the Peripheral Nervous System 2005;10(2):144-57.
  4. Jin HY, Liu WJ, Park JH, Baek HS, Park TS. Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Archives of Medical Research 2009;40(7):536-44.
  5. Carlsson CM. Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. Journal of Alzheimer's Disease 2010;20(3):711-22.
  6. Macpherson H, Formica M, Harris E, Daly RM. Brain functional alterations in Type 2 Diabetes - A systematic review of fMRI studies. Frontiers in Neuroendocrinology 2017.
  7. Walsh EI, Shaw M, Sachdev P, Anstey KJ, Cherbuin N. Brain atrophy in ageing: Estimating effects of blood glucose levels vs. other type 2 diabetes effects. Diabetes and Metabolism 2017.
  8. Hasanein P, Felehgari Z, Emamjomeh A. Preventive effects of Salvia officinalis L. against learning and memory deficit induced by diabetes in rats: Possible hypoglycaemic and antioxidant mechanisms. Neuroscience Letters 2016;622:72-7.
  9. Palleria C, Leo A, Andreozzi F, Citraro R, Iannone M, Spiga R, et al. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects. Behavioural Brain Research 2017;321:157-69.
  10. Fatemi Tabatabaei SR, Rashno M, Ghaderi S, Askaripour M. The Aqueous Extract of Portulaca Oleracea Ameliorates Neurobehavioral Dysfunction and Hyperglycemia Related to Streptozotocin-Diabetes Induced in Ovariectomized Rats. Iranian Journal of Pharmaceutical Research 2016;15(2):561-71.
  11. Wang X, Zhao L. Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway. Biochemical and Biophysical Research Communications 2016;473(2):428-34.
  12. Fried PJ, Schilberg L, Brem AK, Saxena S, Wong B, Cypess AM, et al. Humans with Type-2 Diabetes Show Abnormal Long-Term Potentiation-Like Cortical Plasticity Associated with Verbal Learning Deficits. Journal of Alzheimer's Disease 2017;55(1):89-100.
  13. Tian X, Liu Y, Ren G, Yin L, Liang X, Geng T, et al. Resveratrol limits diabetes-associated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity. Brain Research 2016;1650:1-9.
  14. Alzoubi KH, Khabour OF, Al-Azzam SI, Tashtoush MH, Mhaidat NM. Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress. Current Neuropharmacology 2014;12(2):186-92.
  15. Huang YC, Hsu CC, Lin WC, Yin TK, Huang CW, Wang PW, et al. Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients. Scientific World Journal 2014;2014:694326.
  16. Mousavi SM, Niazmand S, Hosseini M, Hassanzadeh Z, Sadeghnia HR, Vafaee F, et al. Beneficial Effects of Teucrium polium and Metformin on Diabetes-Induced Memory Impairments and Brain Tissue Oxidative Damage in Rats. International Journal of Alzheimers Disease ;2015:493729.
  17. Tikoo K, Sharma E, Amara VR, Pamulapati H, Dhawale VS. Metformin improves metabolic memory in high fat diet (HFD)-induced renal dysfunction. The Journal of Biological Chemistry 2016, in press.
  18. Zhang E, Guo Q, Gao H, Xu R, Teng S, Wu Y. Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway. PLoS One 2015;10(12):e0143814.
  19. Ahshin-Majd S, Zamani S, Kiamari T, Kiasalari Z, Baluchnejadmojarad T, Roghani M. Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: Possible involved mechanisms. Peptides 2016;86:102-11.
  20. Berezin A. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives. Diabetes & Metabolic Syndrome 2016;10(2 Suppl 1):S176-83.
  21. Baluchnejadmojarad T, Kiasalari Z, Afshin-Majd S, Ghasemi Z, Roghani M. S-allyl cysteine ameliorates cognitive deficits in streptozotocin-diabetic rats via suppression of oxidative stress, inflammation, and acetylcholinesterase. European Journal of Pharmacology 2017;794:69-76.
  22. Kalalian-Moghaddam H, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi A. Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. European Journal of Pharmacology 2013;698(1-3):259-66.
  23. Hardigan T, Ward R, Ergul A. Cerebrovascular complications of diabetes: focus on cognitive dysfunction. Clinical Science (London, England: 1979) 2016;130(20):1807-22.
  24. Shinohara M, Sato N. Bidirectional interactions between diabetes and Alzheimer's disease. Neurochemistry International 2017;108:296-302.
  25. Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A. The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications. Nutrients 2017;9(5).
  26. Yu JW, Deng YP, Han X, Ren GF, Cai J, Jiang GJ. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice. Cardiovascular Diabetology 2016;15:88.
  27. Yue R, Fu W, Liao X, Lan C, Liao Q, Li L, et al. Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction. Stem Cell Research & Therapy 2017;8(1):17.
  28. Sharifzadeh M, Ranjbar A, Hosseini A, Khanavi M. The Effect of Green Tea Extract on Oxidative Stress and Spatial Learning in Streptozotocin-diabetic Rats. Iranian Journal of Pharmaceutical Reserach 2017;16(1):201-9.
  29. Wang M, Yan W, Liu Y, Hu H, Sun Q, Chen X, et al. Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo. Scientific Reports 2017;7(1):2801.
  30. Diniz Vilela D, Gomes Peixoto L, Teixeira RR, Belele Baptista N, Carvalho Caixeta D, Vieira de Souza A, et al. The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats. Oxidative Medicine and Cellular Longevity 2016;2016:6978625.
  31. Smieszek A, Strek Z, Kornicka K, Grzesiak J, Weiss C, Marycz K. Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels-An Ex Vivo Study. International Journal of Molecular Science 2017;18(4).
  32. Yang X, Ding H, Qin Z, Zhang C, Qi S, Zhang H, et al. Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo. Oxidative Medicine and Cellular Longevity 2016;2016:4156075.
  33. Rahmeier FL, Zavalhia LS, Tortorelli LS, Huf F, Gea LP, Meurer RT, et al. The effect of taurine and enriched environment on behaviour, memory and hippocampus of diabetic rats Neuroscience Letters 2016;630:84-92.
  34. Chen B, Teng Y, Zhang X, Lv X, Yin Y. Metformin Alleviated Abeta-Induced Apoptosis via the Suppression of JNK MAPK Signaling Pathway in Cultured Hippocampal Neurons. BioMed Research International 2016;2016:1421430.
  35. Chen D, Xia D, Pan Z, Xu D, Zhou Y, Wu Y, et al. Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. Cell Death & Disease 2016;7(10):e2441.